Marcia Belvin insider trades

Open-market stock purchases and sales by Marcia Belvin, SVP, Chief Scientific Officer at CytomX Therapeutics, Inc, from SEC Form 4 filings since Mar 22, 2023.

Recent trades

DateStockTradeValue
Mar 17, 2026CTMX CytomX Therapeutics, IncSold$202K
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—

Companies traded

  • CTMX CytomX Therapeutics, Inc: 7 sales, last Mar 17, 2026

Get free alerts when Marcia Belvin files a new trade →